NCT03163069

Brief Summary

This double-blind randomized controlled clinical trial aimed to investigate the effect of whitening dentifrices on the clinical efficiency of in-office tooth bleaching procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 22, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 24, 2017

Completed
Last Updated

October 10, 2017

Status Verified

October 1, 2017

Enrollment Period

6 months

First QC Date

May 16, 2017

Last Update Submit

October 7, 2017

Conditions

Keywords

tooth bleachingdentifrice

Outcome Measures

Primary Outcomes (1)

  • Change in tooth colour

    Colour parameters (CIE L\*, a\*, b\*) will be measured with a spectrophotometer (Vita Easyshade Advance 4.0). The color alteration after each session will be given by the differences between the values obtained at the sessions and the baseline (∆E).

    4 weeks

Secondary Outcomes (1)

  • Change in tooth whiteness

    4 weeks

Study Arms (3)

Conventional Whitening dentifrice

EXPERIMENTAL

in-office bleaching with the conventional whitening dentifrice

Combination Product: in-office bleaching with the conventional whitening dentifrice

Whitening dentifrice containing blue covarine

EXPERIMENTAL

in-office bleaching with the whitening dentifrice containing blue covarine

Combination Product: in-office bleaching with the whitening dentifrice containing blue covarine

Regular dentifrice

EXPERIMENTAL

in-office bleaching with the regular dentifrice

Combination Product: in-office bleaching with the regular dentifrice

Interventions

Participants will receive in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) for the maxillary anterior teeth (2 sessions, with a 1-week interval). During the tooth bleaching procedure and 3 weeks after the procedure, the participants will be instructed to brush their teeth twice with the conventional whitening dentifrice.

Conventional Whitening dentifrice

Participants will receive in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) for the maxillary anterior teeth (2 sessions, with a 1-week interval). During the tooth bleaching procedure and 3 weeks after the procedure, the participants will be instructed to brush their teeth twice with the whitening dentifrice containing blue covarine.

Whitening dentifrice containing blue covarine

Participants will receive in-office tooth bleaching with 40% hydrogen peroxide (Opalescence Boost PF 40%) for the maxillary anterior teeth (2 sessions, with a 1-week interval). During the tooth bleaching procedure and 3 weeks after the procedure, the participants will be instructed to brush their teeth twice with the regular dentifrice.

Regular dentifrice

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • patients between 18 and 60 years of age, with fully erupted upper and lower incisors and canines without dental or periodontal disease or restorations, and with at least one maxillary tooth presenting color score A3 or darker, as measured with the Vita Classical guide (Vita Zahnfabrik, Bad Sa ̈ ckingen, Germany) ordered by brightness

You may not qualify if:

  • patients with systemic diseases or oral mucosal disorders, previous bleaching treatment, patients undergoing orthodontic treatment, pregnant women, people with known allergy to the product ingredients, smokers, and alcohol abusers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fujian Medical University

Fuzhou, Fujian, 350004, China

Location

MeSH Terms

Conditions

Tooth Discoloration

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Officials

  • Hao Yu

    Fujian Medical University, China

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: factorial assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Fujian Medical University

Study Record Dates

First Submitted

May 16, 2017

First Posted

May 22, 2017

Study Start

January 18, 2017

Primary Completion

July 2, 2017

Study Completion

August 24, 2017

Last Updated

October 10, 2017

Record last verified: 2017-10

Locations